US 11753443
Conjugated hepcidin mimetics
granted A61KA61K38/00A61K38/22
Quick answer
US patent 11753443 (Conjugated hepcidin mimetics) held by Protagonist Therapeutics, Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/22, A61K9/0053, A61P